Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): Pragmatic randomised controlled trial

The BMJ

Volumn 369, Issue , 2020, Pages

  Ivers, Noah M ^a,b,c,d,e   Schwalm, Jon David ^f,g   Bouck, Zachary ^a   McCready, Tara ^f   Taljaard, Monica ^h,i   Grace, Sherry L ^j,k   Cunningham, Jennifer ^f   Bosiak, Beth ^a   Presseau, Justin ^h,i   Witteman, Holly O ^l   Suskin, Neville ^m,n   Wijeysundera, Harindra C ^b,c,d,o   Atzema, Clare ^b,c,d,o   Sacha Bhatia, R ^a,b,c,d,e   Natarajan, Madhu ^f,g   Grimshaw, Jeremy M ^h,i  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j York University   (Canada)

^k University of Toronto   (Canada)

^l UNIVERSITÉ LAVAL   (Canada)

^m ST JOSEPH S HEALTH CENTRE   (Canada)

ⁿ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^o SUNNYBROOK RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEART CENTER; HEART INFARCTION; HEART REHABILITATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; ONTARIO; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTAL MAIL; PRAGMATIC TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TELEMEDICINE; VOLUNTARY WORKER; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; MIDDLE AGED; PATIENT DROPOUT; PATIENT EDUCATION; PROCEDURES; QUALITY OF LIFE; REMINDER SYSTEM; TELEPHONE; TIME FACTOR; TREATMENT OUTCOME;

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC REHABILITATION; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; ONTARIO; PATIENT DROPOUTS; PATIENT EDUCATION AS TOPIC; PLATELET AGGREGATION INHIBITORS; POSTAL SERVICE; QUALITY OF LIFE; REMINDER SYSTEMS; SECONDARY PREVENTION; TELEPHONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85086354865     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.m1731     Document Type: Article

References (51)

1. Antman EM, Hand M, Armstrong PW, et al, Canadian Cardiovascular Society, American Academy of Family Physicians, American College of Cardiology, American Heart Association. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;51:210-47. doi:10.1016/j. jacc.2007.10.001
2. Choudhry NK, Avorn J, Glynn RJ, et al, Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011;365:2088-97. doi:10.1056/NEJMsa1107913
3. Fitchett DH, Theroux P, Brophy JM, et al. Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment-part 2: ST-segment elevation myocardial infarction. Can J Cardiol 2011;27(Suppl A):S402-12. doi:10.1016/j.cjca.2011.08.107
4. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-86. doi:10.1001/ jama.297.2.177
5. Smith SCJr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association [correction in: J Am Coll Cardiol 2015;65:1495]. J Am Coll Cardiol 2011;58:2432-46. doi:10.1016/j.jacc.2011.10.824
6. Schwalm J-D, McKee M, Huffman MD, Yusuf S. Resource effective strategies to prevent and treat cardiovascular disease. Circulation 2016;133:742-55. doi:10.1161/ CIRCULATIONAHA.115.008721
7. Mancini GB, Gosselin G, Chow B, et al, Canadian Cardiovascular Society. Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease. Can J Cardiol 2014;30:837-49. doi:10.1016/j.cjca.2014.05.013
8. Ivers NM, Schwalm J-D, Jackevicius CA, Guo H, Tu JV, Natarajan M. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study. Can J Cardiol 2013;29:1408-14. doi:10.1016/j.cjca.2013.04.009
9. Schwalm J-D, Ivers NM, Natarajan MK, et al. Cluster randomized controlled trial of delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI). Am Heart J 2015;170:903-13. doi:10.1016/j. ahj.2015.08.014
10. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;(7):CD001800. doi:10.1002/14651858.CD001800. pub2
11. Candido E, Richards JA, Oh P, et al. The relationship between need and capacity for multidisciplinary cardiovascular risk-reduction programs in Ontario. Can J Cardiol 2011;27:200-7. doi:10.1016/j. cjca.2011.01.008
12. Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014;(11):CD000011. doi:10.1089/apc.2014.0308
13. Ito K, Shrank WH, Avorn J, et al. Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction. Health Serv Res 2012;47:2097-117. doi:10.1111/ j.1475-6773.2012.01462.x
14. Santiago de Araújo Pio C, Chaves GS, Davies P, Taylor RS, Grace SL. Interventions to promote patient utilisation of cardiac rehabilitation. Cochrane Database Syst Rev 2019;2:CD007131. doi:10.1002/14651858.CD007131.pub4
15. Ivers N, Schwalm JD, Witteman HO, et al. Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): pragmatic randomized trial protocol. Am Heart J 2017;190:64-75. doi:10.1016/j.ahj.2017.05.007
16. El-Menyar A, Zubaid M, AlMahmeed W, et al. Killip classification in patients with acute coronary syndrome: insight from a multicenter registry. Am J Emerg Med 2012;30:97-103. doi:10.1016/j. ajem.2010.10.011
17. Presseau J, Schwalm JD, Grimshaw JM, et al. Identifying determinants of medication adherence following myocardial infarction using the Theoretical Domains Framework and the Health Action Process Approach. Psychol Health 2017;32:1176-94. doi:10.1080/088704 46.2016.1260724
18. Witteman HO, Presseau J, Nicholas Angl E, et al. Negotiating tensions between theory and design in the development of mailings for people recovering from acute coronary syndrome. JMIR Hum Factors 2017;4:e6. doi:10.2196/humanfactors.6502
19. Sniehotta FF, Scholz U, Schwarzer R. Action plans and coping plans for physical exercise: a longitudinal intervention study in cardiac rehabilitation. Br J Health Psychol 2006;11:23-37. doi:10.1348/135910705X43804
20. Khan M, Lamelas P, Musa H, et al. Development, testing, and implementation of a training curriculum for nonphysician health workers to reduce cardiovascular disease. Glob Heart 2018;13:93-100.e1. doi:10.1016/j.gheart.2017.11.002
21. Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 2009;10:37. doi:10.1186/1745-6215-10-37
22. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 2007;297:831-41. doi:10.1001/ jama.297.8.831
23. Kayaniyil S, Leung YW, Suskin N, Stewart DE, Grace SL. Concordance of self-and program-reported rates of cardiac rehabilitation referral, enrollment and participation. Can J Cardiol 2009;25:e96-9. doi:10.1016/S0828-282X(09)70063-7
24. Nieuwkerk PT, Nierman MC, Vissers MN, et al. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol 2012;110:666-72. doi:10.1016/j.amjcard.2012.04.045
25. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57. doi:10.1097/00005650-199909000-00002
26. Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovasc Qual Outcomes 2014;7:640-7. doi:10.1161/ CIRCOUTCOMES.114.000967
27. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 2007;167:1798-803. doi:10.1001/archinte.167.16.1798
28. Alter DA, Oh PI, Chong A. Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system. Eur J Cardiovasc Prev Rehabil 2009;16:102-13. doi:10.1097/HJR.0b013e328325d662
29. Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. JAMA 2006;295:1168-70. doi:10.1001/ jama.295.10.1168
30. Degrauwe S, Pilgrim T, Aminian A, Noble S, Meier P, Iglesias JF. Dual antiplatelet therapy for secondary prevention of coronary artery disease. Open Heart 2017;4:e000651. doi:10.1136/ openhrt-2017-000651
31. Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Pharmacy Quality Alliance, 2012.
32. Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res 2011;2:109-12. doi:10.4103/2229-3485.83221
33. Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ 2012;345:e5840. doi:10.1136/bmj.e5840
34. Pedroza C, Truong VT. Performance of models for estimating absolute risk difference in multicenter trials with binary outcome. BMC Med Res Methodol 2016;16:113. doi:10.1186/s12874-016-0217-0
35. Dmitrienko A, D'Agostino RBSr, Huque MF. Key multiplicity issues in clinical drug development. Stat Med 2013;32:1079-111. doi:10.1002/sim.5642
36. Walters SJ. Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36. Health Qual Life Outcomes 2004;2:26. doi:10.1186/1477-7525-2-26
37. Mosleh SM, Bond CM, Lee AJ, Kiger A, Campbell NC. Effectiveness of theory-based invitations to improve attendance at cardiac rehabilitation: a randomized controlled trial. Eur J Cardiovasc Nurs 2014;13:201-10. doi:10.1177/1474515113491348
38. Wyer S, Earll L, Joseph S, Harrison J, Giles M, Johnston M. Increasing attendance at a cardiac rehabilitation programme: an intervention study using the Theory of Planned Behaviour. Coron Health Care 2001;5:154-9. doi:10.1054/chec.2001.0131.
39. Tsoli S, Sutton S, Kassavou A. Interactive voice response interventions targeting behaviour change: a systematic literature review with meta-analysis and meta-regression. BMJ Open 2018;8:e018974. doi:10.1136/bmjopen-2017-018974
40. Smith DH, O'Keeffe-Rosetti M, Owen-Smith AA, et al. Improving adherence to cardiovascular therapies: an economic evaluation of a randomized pragmatic trial. Value Health 2016;19:176-84. doi:10.1016/j.jval.2015.11.013
41. Sherrard H, Struthers C, Kearns SA, Wells G, Chen L, Mesana T. Using technology to create a medication safety net for cardiac surgery patients: a nurse-led randomized control trial. Can J Cardiovasc Nurs 2009;19:9-15.
42. Kassavou A, Sutton S. Automated telecommunication interventions to promote adherence to cardio-metabolic medications: metaanalysis of effectiveness and meta-regression of behaviour change techniques. Health Psychol Rev 2018;12:25-42. doi:10.1080/1743 7199.2017.1365617
43. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. B. Departures from General Principles of Consent. In: Tri-Council Policy Statement: Ethical conduct for research involving humans, 2014. https://ethics.gc.ca/eng/tcps2-eptc2_chapter3-chapitre3.html#toc03-1b
44. Grady D, Redberg RF, O'Malley PG. Quality improvement for quality improvement studies. JAMA Intern Med 2018;178:187. doi:10.1001/jamainternmed.2017.6875
45. Ivers NM, Grimshaw JM. Reducing research waste with implementation laboratories. Lancet 2016;388:547-8. doi:10.1016/ S0140-6736(16)31256-9
46. Robert J. Embedding research in the learning health system. Healthc Pap 2016;16:30-5. https://www.longwoods.com/content/24724/ healthcarepapers/embedding-research-in-the-learning-healthsystem
47. Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care 2007;45(Supl 2):S38-43. doi:10.1097/MLR.0b013e318070c0a0
48. Firmino-Machado J, Mendes R, Moreira A, Lunet N. Stepwise strategy to improve Cervical Cancer Screening Adherence (SCAN-CC): automated text messages, phone calls and face-to-face interviews: protocol of a population-based randomised controlled trial. BMJ Open 2017;7:e017730. doi:10.1136/bmjopen-2017-017730
49. Thakkar J, Kurup R, Laba T-L, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 2016;176:340-9. doi:10.1001/ jamainternmed.2015.7667
50. Chow CK, Thiagalingam A, Santo K, et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open 2018;8:e019463. doi:10.1136/bmjopen-2017-019463
51. Moghei M, Oh P, Chessex C, Grace SL. Cardiac rehabilitation quality improvement: a narrative review. J Cardiopulm Rehabil Prev 2019;39:226-34. doi:10.1097/HCR.0000000000000396